FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4690011000001100: Lopinavir 400mg/5ml / Ritonavir 100mg/5ml oral solution 300 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21261501000001113 Lopinavir 400mg/5ml / Ritonavir 100mg/5ml oral solution 300 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21261601000001112 Lopinavir 400mg/5ml / Ritonavir 100mg/5ml oral solution 300 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lopinavir 400mg/5ml / Ritonavir 100mg/5ml oral solution 300 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lopinavir 400mg/5ml / Ritonavir 100mg/5ml oral solution 300 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Lopinavir 400mg/5ml / Ritonavir 100mg/5ml oral solution 300 ml Is pack of Product containing precisely lopinavir 80 milligram/1 milliliter and ritonavir 20 milligram/1 milliliter conventional release oral solution false Inferred relationship Existential restriction modifier
Lopinavir 400mg/5ml / Ritonavir 100mg/5ml oral solution 300 ml Has active ingredient Ritonavir false Inferred relationship Existential restriction modifier
Lopinavir 400mg/5ml / Ritonavir 100mg/5ml oral solution 300 ml Has active ingredient Lopinavir false Inferred relationship Existential restriction modifier
Lopinavir 400mg/5ml / Ritonavir 100mg/5ml oral solution 300 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lopinavir 400mg/5ml / Ritonavir 100mg/5ml oral solution 300 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lopinavir 400mg/5ml / Ritonavir 100mg/5ml oral solution 300 ml Has manufactured dose form Conventional release oral solution false Inferred relationship Existential restriction modifier
Lopinavir 400mg/5ml / Ritonavir 100mg/5ml oral solution 300 ml Has VMP Product containing precisely lopinavir 80 milligram/1 milliliter and ritonavir 20 milligram/1 milliliter conventional release oral solution true Inferred relationship Existential restriction modifier
Lopinavir 400mg/5ml / Ritonavir 100mg/5ml oral solution 300 ml Has specific active ingredient Lopinavir true Inferred relationship Existential restriction modifier
Lopinavir 400mg/5ml / Ritonavir 100mg/5ml oral solution 300 ml Has specific active ingredient Ritonavir true Inferred relationship Existential restriction modifier
Lopinavir 400mg/5ml / Ritonavir 100mg/5ml oral solution 300 ml Has dispensed dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Kaletra oral solution (Abbott Laboratories Ltd) 300 ml 5 x 60ml bottles Is a True Lopinavir 400mg/5ml / Ritonavir 100mg/5ml oral solution 300 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start